TVTX Competitors & Alternatives
Compare Travere Therapeutics Inc with similar stocks in the same industry
Biotechnology
TVTX
Main Stock$51.96
Tradestie Score
57
Market Cap
$2.21B
Revenue Growth
0.4%
Analyst Upside
+41.3%
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRSP
CRISPR Therapeutics AG
|
$42.90
|
$6.02B | - | 49 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$144.78
|
$5.92B | - | 55 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$65.46
|
$5.80B | 95.9 | 30 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$306.37
|
$5.20B | 41.6 | 50 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$65.39
|
$4.94B | - | 38 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$63.57
|
$4.93B | - | 44 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$47.43
|
$4.84B | - | 50 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$135.37
|
$3.98B | 28.8 | 45 | Compare |
More TVTX Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
215 stocks in this industry